Apr 4 |
Madrigal Pharmaceuticals Inc Director Kenneth Bate Sells 32,489 Shares
|
Apr 3 |
Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
|
Apr 3 |
1 No-Brainer Growth Stock to Buy Now
|
Apr 2 |
The 3 Best Biotech Stocks to Buy in April 2024
|
Mar 29 |
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
|
Mar 29 |
Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?
|
Mar 26 |
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
|
Mar 22 |
This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?
|
Mar 19 |
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
|
Mar 19 |
Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
|